MYLK Gene Aortic Aneurysm Familial Thoracic Type 7 Genetic Test
Components
- Test Name: MYLK Gene Aortic Aneurysm Familial Thoracic Type 7 Genetic Test
- Price: 3200.0 AED
- Sample Condition: Blood or Extracted DNA or One drop Blood on FTA Card
- Report Delivery: 3 to 4 Weeks
- Method: NGS Technology
- Test Type: Vascular Diseases
- Doctor: General Physician
- Test Department: Genetics
- Pre Test Information: Clinical History of Patient who is going for MYLK Gene Aortic Aneurysm, familial thoracic type 7 NGS Genetic DNA Test. A Genetic Counselling session to draw a pedigree chart of family members affected with MYLK Gene Aortic Aneurysm, familial thoracic type 7 NGS Genetic DNA Test gene MYLK
Test Details
The MYLK gene is associated with familial thoracic aortic aneurysm type 7, which is an inherited condition characterized by the weakening and dilation of the aorta in the thoracic (chest) region. This condition can lead to potentially life-threatening complications such as aortic dissection or rupture.
NGS (Next-Generation Sequencing) genetic testing is a type of genetic test that can analyze multiple genes simultaneously to identify any mutations or variants that may be associated with a specific condition. In the case of familial thoracic aortic aneurysm type 7, an NGS genetic test can be used to detect any mutations in the MYLK gene that may be causing or predisposing an individual to this condition.
By identifying these genetic mutations, individuals at risk for familial thoracic aortic aneurysm type 7 can be diagnosed early and appropriate management strategies can be implemented to reduce the risk of complications. This may include regular monitoring, lifestyle modifications, and in some cases, surgical intervention.
It is important to note that genetic testing should be conducted under the guidance of a healthcare professional or genetic counselor who can provide appropriate counseling and interpretation of the results.
Test Name | MYLK Gene Aortic aneurysm familial thoracic type 7 Genetic Test |
---|---|
Components | |
Price | 3200.0 AED |
Sample Condition | Blood or Extracted DNA or One drop Blood on FTA Card |
Report Delivery | 3 to 4 Weeks |
Method | NGS Technology |
Test type | Vascular Diseases |
Doctor | General Physician |
Test Department: | Genetics |
Pre Test Information | Clinical History of Patient who is going for MYLK Gene Aortic aneurysm, familial thoracic type 7 NGS Genetic DNA Test. A Genetic Counselling session to draw a pedigree chart of family members affected with MYLK Gene Aortic aneurysm, familial thoracic type 7 NGS Genetic DNA Test gene MYLK |
Test Details |
The MYLK gene is associated with familial thoracic aortic aneurysm type 7, which is an inherited condition characterized by the weakening and dilation of the aorta in the thoracic (chest) region. This condition can lead to potentially life-threatening complications such as aortic dissection or rupture. NGS (Next-Generation Sequencing) genetic testing is a type of genetic test that can analyze multiple genes simultaneously to identify any mutations or variants that may be associated with a specific condition. In the case of familial thoracic aortic aneurysm type 7, an NGS genetic test can be used to detect any mutations in the MYLK gene that may be causing or predisposing an individual to this condition. By identifying these genetic mutations, individuals at risk for familial thoracic aortic aneurysm type 7 can be diagnosed early and appropriate management strategies can be implemented to reduce the risk of complications. This may include regular monitoring, lifestyle modifications, and in some cases, surgical intervention. It is important to note that genetic testing should be conducted under the guidance of a healthcare professional or genetic counselor who can provide appropriate counseling and interpretation of the results. |